alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 35.1

Servicer Compliance Statement of AmeriCredit Financial Services, Inc.

This Annual Statement as to Compliance is delivered to you pursuant to Section 4.10 (a) of the Sale and Servicing Agreement dated as of June 4,
2014 (the Agreement) and Item 1123 of Regulation AB, executed in connection with the formation of AmeriCredit Automobile Receivables Trust 2014-2 (the Trust), the issuance of the Notes by the Trust and the closing of the
transactions and the execution and delivery of the various documents by General Motors Financial Company, Inc. (f/k/a AmeriCredit Corp.), AmeriCredit Financial Services, Inc. (the Servicer) and AFS SenSub Corp. in connection therewith.
The capitalized terms used herein shall have the same meanings as in the Agreement.

The undersigned certifies that I am the Executive
Vice President, Corporate Controller and Chief Accounting Officer of the Servicer. I further certify as follows:



| | 1. | I have conducted, or caused to be conducted under my supervision, a review of the Servicer during the preceding period from June 4, 2014 through December 31, 2014, and its performance under the Agreement.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, following such review, the Servicer has fulfilled all its obligations under the Agreement throughout such period, and, to the best of my knowledge, there has been no default in the
fulfillment of any such obligation.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AmeriCredit Financial Services, Inc.



|    |  |                                         |  |                      
|--- |  | --------------------------------------- |  | ---------------------
|By: |  | /s/ Connie Coffey                       |  | Dated: March 30, 2015
|    |  | Connie Coffey                           |  |                      
|    |  | Executive Vice President, Corporate     |  |                      
|    |  | Controller and Chief Accounting Officer |  |
**Exhibit 31.1**CERTIFICATIONI, **Jeffrey A. Hawthorne**, certify that:1. I have reviewed this Annual Report on Form 10-K/A, Amendment No. 3 of Photon Dynamics, Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forthe registrant and have:(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and(c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing the equivalent functions):(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting./s/Jeffrey A. Hawthorne **Jeffrey A. Hawthorne**
exv10w13






Exhibit 10.13




2010 Management Incentive Plan – Performance Criteria




     Under the Management Incentive Program (“MIP”) of The Talbots, Inc. (the “Company”), based on
and subject to achieving pre-established financial performance goals, cash incentive awards may be
made annually to those eligible management employees who are in certain position levels within the
Company including executive officers. Under the MIP, the following formula will be applied in
determining annual incentive compensation awards for fiscal 2010: base annual salary x executive’s
target incentive percentage x performance achievement rating. For fiscal 2010, the Compensation
Committee of the Board of Directors (the “Committee) approved the following objective performance
measures under the MIP: income from continuing operations (60%), return on invested capital (20%)
and achievement of individual goals (20%). For each financial performance measure, a participant
earns 50% of his or her target award if actual achievement equals “threshold” performance; 100% of
his or her target award if achievement equals “target” performance; and 200% of his or her target
award if achievement is equal to or above “maximum performance.” Achievement below “threshold” for
any performance measure results in no award for that performance measure. If actual achievement is
below “threshold” for “operating income from continuing operations”, no annual cash incentive award
will be payable for any of the MIP performance measures. Awards made under the MIP are subject to
the discretion of the Committee.
Exhibit 32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002 In
connection with the Annual Report of Speedus Corp. (the Company) on Form 10-K
for the period ending December 31, 2007 as filed with the Securities and
Exchange Commission on the date hereof (the Report), I, Thomas M. Finn,
Treasurer and Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that: (1)
The Report
  fully complies with the requirements of Section 13(a) or15(d) of the
  Securities Exchange of 1934, amended; and(2)
The
  information contained in the Report fairly presents, in all material
  respects, the financial condition and results of operations of the Company.  Date:

March 31,
  2008By:

/s/ Thomas
  M. FinnName:

Thomas M.
  FinnTitle:

Treasurer
  and Chief Financial Officer 5
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

ARMANDO VALENCIA CHAVEZ;

NORMA SYLVIA VALENCIA,

 Petitioners,

 v.

ERIC H. HOLDER, Attorney General,

 Respondent.

No. 08-71934

Agency Nos. A070-913-944

A070-913-945

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted August 10, 2010** 

Before: O’SCANNLAIN, HAWKINS, and IKUTA, Circuit Judges.

Armando Valencia Chavez and Norma Sylvia Valencia, natives and citizens

of Mexico, petition for review of the Board of Immigration Appeals’ order

summarily affirming an immigration judge’s (“IJ”) decision denying their

applications for cancellation of removal for failure to prosecute. We have

FILED

AUG 27 2010

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 08-71934

jurisdiction under 8 U.S.C. § 1252. We review de novo questions of law, including

due process claims, Ram v. INS, 243 F.3d 510, 516 (9th Cir. 2001), and we review

for abuse of discretion the pretermission of an application for cancellation of

removal for failure to comply with fingerprinting regulations. See Cui v. Mukasey,

538 F.3d 1289, 1291-92 (9th Cir. 2008). We deny the petition for review.

The IJ did not abuse his discretion by pretermitting petitioners’ application

for cancellation of removal, where petitioners failed to comply with the

requirements to provide their fingerprints within the time authorized by the IJ. See

8 C.F.R. § 1003.47(c). The IJ instructed petitioners in both oral and written format

to submit themselves for fingerprinting, informed them of the consequences of a

failure to do so, and had already granted one continuance due to their

misunderstanding of fingerprint regulations, yet ten months later petitioners could

not provide a reasonable explanation for their failure to comply with the

fingerprinting requirement. Accordingly, the petitioners have not established that

their failure to comply was a result of good cause. See id.; cf. Cui, 538 F.3d at

1293-9. Petitioners’ due process contention fails as well. See Lata v. INS, 204

F.3d 1241, 1246 (9th Cir. 2000) (requiring agency error for a petitioner to establish

a violation of due process).

PETITION FOR REVIEW DENIED.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED April 18, 2007 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 06-40384 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee, versus JOHNNY GUZMAN, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Southern District of Texas USDC No. 5:05-CR-1424-1

-------------------- Before HIGGINBOTHAM, BENAVIDES, and PRADO, Circuit Judges.
PER CURIAM: * The attorney appointed to represent Johnny Guzman has requested leave to withdraw and has filed a brief as required by Anders v. California , 386 U.S. 738 (1967). Guzman has not filed a response. Our independent review of the brief and the record discloses no nonfrivolous issue for appeal. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS
DISMISSED. See 5 TH C IR . R. 42.2.
Exhibit 32

CERTIFICATIONS UNDER SECTION 906

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title
18, United States Code), each of the undersigned officers of Orchid Cellmark Inc., a Delaware corporation (the Company), does hereby certify, to such officers knowledge, that:

The Quarterly Report for the quarter ended March 31, 2010 (the Form 10-Q) of the Company fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                   |  |  |  |  |  |                                                                                                       
|------------------ |  |  |  |  |  | ------------------------------------------------------------------------------------------------------
|                   |  |  | 
|Dated: May 7, 2010 |  |  |  |  |  | /S/    THOMAS A. BOLOGNA                                                                              
|                   |  |  |  |  |  | Thomas A. Bologna
President and Chief Executive Officer
(Principal Executive Officer)                 
|                   |  |  | 
|Dated: May 7, 2010 |  |  |  |  |  | /S/    JAMES F. SMITH                                                                                 
|                   |  |  |  |  |  | James F. Smith
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                              <C>                     <C> 
<PERIOD-TYPE>                    YEAR                    YEAR
<FISCAL-YEAR-END>                         DEC-31-1998             DEC-31-1997
<PERIOD-START>                            JAN-01-1998             JAN-01-1997
<PERIOD-END>                              DEC-31-1998             DEC-31-1997
<CASH>                                            623                   3,213 
<SECURITIES>                                        0                       0
<RECEIVABLES>                                   5,946                   3,651
<ALLOWANCES>                                        0                       0
<INVENTORY>                                         0                       0
<CURRENT-ASSETS>                               36,828                  18,494 
<PP&E>                                      1,709,487               1,074,929
<DEPRECIATION>                                 72,153                  32,188
<TOTAL-ASSETS>                              1,694,582               1,070,891
<CURRENT-LIABILITIES>                         128,341                  82,839
<BONDS>                                       653,000                 135,000
<PREFERRED-MANDATORY>                               0                       0
<PREFERRED>                                         0                       0
<COMMON>                                          960                     956
<OTHER-SE>                                    865,791                 833,703
<TOTAL-LIABILITY-AND-EQUITY>                1,694,582               1,070,891
<SALES>                                             0                       0 
<TOTAL-REVENUES>                              283,087                       0
<CGS>                                               0                       0
<TOTAL-COSTS>                                 122,469                       0 
<OTHER-EXPENSES>                               93,366                       0 
<LOSS-PROVISION>                                    0                       0 
<INTEREST-EXPENSE>                             20,521                       0 
<INCOME-PRETAX>                                46,731                       0 
<INCOME-TAX>                                   18,693                       0 
<INCOME-CONTINUING>                            28,038                       0 
<DISCONTINUED>                                      0                       0 
<EXTRAORDINARY>                                     0                       0 
<CHANGES>                                           0                       0 
<NET-INCOME>                                   28,038                       0 
<EPS-PRIMARY>                                    0.29                       0 
<EPS-DILUTED>                                    0.29                       0 
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [File No. 500-1]

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of AuraSound, Inc. because it has not filed any periodic reports since the period ended December 31, 2011.

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of C2C CrowdFunding, Inc. because it has not filed any periodic reports since the period ended September 30, 2012.

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Convenience TV Inc. because it has not filed any periodic reports since the period ended September 30, 2012.

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Global Security Agency Inc. because it has not filed any periodic reports since the period ended September 30, 2012.

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of NewMarket Technology, Inc. because it has not filed any periodic reports since the period ended June 30, 2011.

The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed companies is suspended for the period from 9:30 a.m. EDT on April 7, 2015, through 11:59 p.m. EDT on April 20, 2015.

By the Commission.

Jill M. Peterson,

Assistant Secretary.

[FR Doc. 2015-08261 Filed 4-7-15; 4:15 pm]

 BILLING CODE 8011-01-P
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 21-0465

STATE OF MONTANA,

Plaintiff and Appellee,

v.

THOMAS RALPH BRISTOW,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, and 

good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including June 27, 2022, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

May 20 2022

05/20/2022

Case Number: DA 21-0465
Order entered September 30, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-15-00851-CV

MERRITT, HAWKINS & ASSOCIATES, LLC, Appellant

V.

CHRIS CAPORICCI AND MATTHEW CUMMINS, Appellees

On Appeal from the 134th Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC-13-13851

ORDER

We GRANT appellant’s September 28, 2015 unopposed motion to extend time to file 

brief and ORDER the brief be filed no later than October 19, 2015.

/s/ CRAIG STODDART 

JUSTICE
[Federal Register Volume 87, Number 1 (Monday, January 3, 2022)]
[Notices]
[Page 105]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28411]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2022-1 Phase 
I: Data Science Tools for Infectious and Immune-Mediated Disease 
Research (Topic 111).
    Date: February 8, 2022.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G42, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G42, 
Rockville, MD 20852, (240) 282-0189, <a href="/cdn-cgi/l/email-protection#1360727d777a633d717b72676772707b72616a6a72537d7a7b3d747c65"><span class="__cf_email__" data-cfemail="f586949b919c85db979d94818194969d94878c8c94b59b9c9ddb929a83">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28411 Filed 12-30-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>